|
NUP43 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.416100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.721510E-02 |
| Normal-vs-Stage2 |
4.323600E-02 |
| Normal-vs-Stage3 |
1.006880E-04 |
| Normal-vs-Stage4 |
1.502670E-03 |
| Stage1-vs-Stage2 |
4.560600E-01 |
| Stage1-vs-Stage3 |
3.607600E-02 |
| Stage1-vs-Stage4 |
1.668390E-01 |
| Stage2-vs-Stage3 |
6.333200E-01 |
| Stage2-vs-Stage4 |
8.607800E-01 |
| Stage3-vs-Stage4 |
6.642000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.354000E-04 |
| Normal-vs-AfricanAmerican |
3.331800E-02 |
| Normal-vs-Asian |
7.756000E-01 |
| Caucasian-vs-AfricanAmerican |
7.982400E-01 |
| Caucasian-vs-Asian |
4.294600E-01 |
| AfricanAmerican-vs-Asian |
4.699800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.030900E-04 |
| Normal-vs-Female |
1.445730E-02 |
| Male-vs-Female |
2.080000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.498000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.172300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.024190E-04 |
| Normal-vs-Age(81-100Yrs) |
1.980980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.604400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.862600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.111200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.913900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.430800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.918800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.140000E-01 |
| Normal-vs-Grade 2 |
6.069900E-02 |
| Normal-vs-Grade 3 |
1.030140E-04 |
| Normal-vs-Grade 4 |
1.60029999995981E-06 |
| Grade 1-vs-Grade 2 |
2.449600E-01 |
| Grade 1-vs-Grade 3 |
2.403700E-02 |
| Grade 1-vs-Grade 4 |
1.744320E-03 |
| Grade 2-vs-Grade 3 |
3.161900E-02 |
| Grade 2-vs-Grade 4 |
9.586100E-04 |
| Grade 3-vs-Grade 4 |
1.175600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.740800E-01 |
| Normal-vs-ccB subtype |
1.86644999999874E-05 |
| ccA subtype-vs-ccB subtype |
2.172400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.489700E-02 |
| Normal-vs-N1 |
5.096000E-03 |
| N0-vs-N1 |
1.590370E-01 |
|
|
